Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentparaspeckles

SFPQ NONO

7.40e-061092GO:0042382
GeneOntologyCellularComponentneuron projection cytoplasm

SFPQ KIF3C

9.64e-0411092GO:0120111
GeneOntologyCellularComponentnuclear matrix

SFPQ NONO

1.55e-0314092GO:0016363
GeneOntologyCellularComponenttranscription regulator complex

WWTR1 SFPQ NONO

1.70e-0359693GO:0005667
GeneOntologyCellularComponentfibrillar center

AFF4 NONO

1.92e-0315692GO:0001650
GeneOntologyCellularComponentnuclear periphery

SFPQ NONO

2.31e-0317192GO:0034399
GeneOntologyCellularComponentnuclear body

WWTR1 SFPQ NONO

5.55e-0390393GO:0016604
GeneOntologyCellularComponentRNA polymerase II transcription regulator complex

SFPQ NONO

5.72e-0327292GO:0090575
GeneOntologyCellularComponentplasma membrane bounded cell projection cytoplasm

SFPQ KIF3C

7.69e-0331792GO:0032838
MousePhenoabnormal rhythmic behavior

SFPQ KIF3C NONO

1.03e-0420473MP:0021121
DomainNOPS

SFPQ NONO

6.19e-07392PF08075
DomainNOPS

SFPQ NONO

6.19e-07392IPR012975
DomainRRM_1

SFPQ NONO

4.22e-0320892PF00076
DomainRRM

SFPQ NONO

4.58e-0321792SM00360
DomainRRM_dom

SFPQ NONO

5.00e-0322792IPR000504
DomainRRM

SFPQ NONO

5.13e-0323092PS50102
Domain-

SFPQ NONO

5.76e-03244923.30.70.330
DomainNucleotide-bd_a/b_plait

SFPQ NONO

6.42e-0325892IPR012677
Pubmed

The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation.

SFPQ NONO

5.95e-0829225765647
Pubmed

PSF and p54(nrb)/NonO--multi-functional nuclear proteins.

SFPQ NONO

5.95e-0829212417296
Pubmed

Purification and characterization of a DNA-binding heterodimer of 52 and 100 kDa from HeLa cells.

SFPQ NONO

5.95e-082928439294
Pubmed

Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism.

SFPQ NONO

5.95e-0829235886974
Pubmed

Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.

SFPQ NONO

5.95e-0829225605962
Pubmed

The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha.

SFPQ NONO

5.95e-0829217965020
Pubmed

SFPQ•NONO and XLF function separately and together to promote DNA double-strand break repair via canonical nonhomologous end joining.

SFPQ NONO

5.95e-0829227924002
Pubmed

PSF/p54(nrb) stimulates "jumping" of DNA topoisomerase I between separate DNA helices.

SFPQ NONO

5.95e-0829210858305
Pubmed

PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression.

SFPQ NONO

5.95e-0829212944487
Pubmed

Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor.

SFPQ NONO

5.95e-0829215590677
Pubmed

Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1.

SFPQ AFF4 NONO

1.69e-07459333596420
Pubmed

hnRNP M interacts with PSF and p54(nrb) and co-localizes within defined nuclear structures.

SFPQ NONO

1.79e-0739219874820
Pubmed

RNF8 mediates NONO degradation following UV-induced DNA damage to properly terminate ATR-CHK1 checkpoint signaling.

SFPQ NONO

1.79e-0739230445466
Pubmed

Proteomic identification of a PSF/p54nrb heterodimer as RNF43 oncoprotein-interacting proteins.

SFPQ NONO

1.79e-0739218655028
Pubmed

Quantitative proteomics reveals dynamic interaction of c-Jun N-terminal kinase (JNK) with RNA transport granule proteins splicing factor proline- and glutamine-rich (Sfpq) and non-POU domain-containing octamer-binding protein (Nono) during neuronal differentiation.

SFPQ NONO

1.79e-0739225326457
Pubmed

PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription.

SFPQ NONO

1.79e-0739216641145
Pubmed

The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination.

SFPQ NONO

1.79e-0739217639083
Pubmed

Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins.

SFPQ NONO

1.79e-0739222213094
Pubmed

The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.

SFPQ NONO

1.79e-0739215790595
Pubmed

The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs.

SFPQ NONO

1.79e-0739211525732
Pubmed

Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response.

SFPQ NONO

1.79e-0739220421735
Pubmed

P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner.

SFPQ NONO

1.79e-0739216148043
Pubmed

Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma.

SFPQ NONO

1.79e-073929393982
Pubmed

Murine Long Noncoding RNA Morrbid Contributes in the Regulation of NRAS Splicing in Hepatocytes In Vitro.

SFPQ NONO

3.57e-0749232764370
Pubmed

Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.

SFPQ NONO

3.57e-0749227259250
Pubmed

The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction.

SFPQ NONO

3.57e-074929756848
Pubmed

Transcriptional activity of androgen receptor is modulated by two RNA splicing factors, PSF and p54nrb.

SFPQ NONO

5.95e-0759217452459
Pubmed

Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.

SFPQ NONO

5.95e-0759211897684
Pubmed

Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR.

SFPQ NONO

5.95e-0759217507659
Pubmed

Dynamic paraspeckle component localisation during spermatogenesis.

SFPQ NONO

5.95e-0759231299635
Pubmed

Distinct roles of DBHS family members in the circadian transcriptional feedback loop.

SFPQ NONO

5.95e-0759222966205
Pubmed

NEAT1 scaffolds RNA-binding proteins and the Microprocessor to globally enhance pri-miRNA processing.

SFPQ NONO

5.95e-0759228846091
Pubmed

The mitotic phosphorylation of p54(nrb) modulates its RNA binding activity.

SFPQ NONO

5.95e-0759221819346
Pubmed

PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors.

SFPQ NONO

8.92e-0769211259580
Pubmed

Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1).

SFPQ NONO

8.92e-0769219389484
Pubmed

Characterization of telomeric repeat-containing RNA (TERRA) localization and protein interactions in primordial germ cells of the mouse†.

SFPQ NONO

8.92e-0769230423030
Pubmed

Malat1 is not an essential component of nuclear speckles in mice.

SFPQ NONO

1.25e-0679222718948
Pubmed

PSF and p54nrb bind a conserved stem in U5 snRNA.

SFPQ NONO

1.25e-0679212403470
Pubmed

Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).

SFPQ NONO

1.67e-0689218042045
Pubmed

Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSF.

SFPQ NONO

2.14e-0699221566083
Pubmed

Transcription factor protein interactomes reveal genetic determinants in heart disease.

SFPQ NONO CDC42BPA SPTY2D1

2.31e-064119435182466
Pubmed

HEXIM1 and NEAT1 Long Non-coding RNA Form a Multi-subunit Complex that Regulates DNA-Mediated Innate Immune Response.

SFPQ NONO

2.68e-06109228712728
Pubmed

Purification and identification of protein-tyrosine kinase-binding proteins using synthetic phosphopeptides as affinity reagents.

SFPQ NONO

3.27e-06119215215307
Pubmed

IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.

SFPQ NONO

4.64e-06139230725116
Pubmed

A molecular mechanism for circadian clock negative feedback.

SFPQ NONO

4.64e-06139221680841
Pubmed

Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression.

SFPQ NONO

4.64e-06139219144721
Pubmed

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.

SFPQ AFF4 NONO

6.23e-061489332538781
Pubmed

Hem-1 complexes are essential for Rac activation, actin polymerization, and myosin regulation during neutrophil chemotaxis.

SFPQ NONO

6.24e-06159216417406
Pubmed

Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.

SFPQ NONO

1.02e-05199234467244
Pubmed

TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.

SFPQ NONO

1.37e-05229217803295
Pubmed

Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells.

SFPQ NONO

1.50e-05239221670149
Pubmed

Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.

SFPQ NONO

2.24e-05289219596686
Pubmed

An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.

SFPQ NONO

2.41e-05299219279220
Pubmed

The periphilin 1-like BFAR isoform 3 is highly expressed in transcriptionally silent oocytes and involved in RNA metabolism.

SFPQ NONO

2.41e-05299234175335
Pubmed

Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.

SFPQ NONO

2.58e-05309234017080
Pubmed

Proteomic analysis of complexes formed by human topoisomerase I.

SFPQ NONO

2.94e-05329215848144
Pubmed

Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions.

SFPQ NONO

2.94e-05329219542561
Pubmed

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.

SFPQ NONO

2.94e-05329236252997
Pubmed

Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma.

SFPQ NONO

2.94e-05329231815296
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

SFPQ KIF3C NONO CDC42BPA

3.34e-058099432129710
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

SFPQ AFF4 NONO

4.32e-052839330585729
Pubmed

R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.

SFPQ NONO CDC42BPA

5.14e-053009328561026
Pubmed

Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.

SFPQ NONO

5.35e-05439226030138
Pubmed

Functional specialization of beta-arrestin interactions revealed by proteomic analysis.

SFPQ NONO APLP1

6.05e-053179317620599
Pubmed

The SMN interactome includes Myb-binding protein 1a.

SFPQ NONO

6.12e-05469219928837
Pubmed

Hdac6 regulates Tip60-p400 function in stem cells.

SFPQ NONO

6.67e-05489224302573
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

SFPQ AFF4 NONO SPTY2D1

7.31e-059899436424410
Pubmed

Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.

SFPQ NONO

7.84e-05529224591637
Pubmed

Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells.

SFPQ NONO

8.15e-05539236841324
Pubmed

The nuclear transcription factor RARalpha associates with neuronal RNA granules and suppresses translation.

SFPQ NONO

8.46e-05549218495661
Pubmed

CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).

SFPQ NONO

8.78e-05559223178491
Pubmed

Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer.

SFPQ NONO

9.43e-05579238223760
Pubmed

Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.

SFPQ AFF4

1.01e-04599228813667
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

SFPQ AFF4 NONO CDC42BPA

1.04e-0410829438697112
Pubmed

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.

SFPQ NONO

1.15e-04639237052853
Pubmed

14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.

SFPQ NONO

1.27e-04669223472066
Pubmed

The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically.

SFPQ NONO

1.27e-04669232051553
Pubmed

SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.

SFPQ NONO

1.27e-04669236095012
Pubmed

Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.

SFPQ NONO

1.64e-04759231527668
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

WWTR1 SFPQ NONO

1.79e-044579332344865
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

SFPQ AFF4 NONO CDC42BPA

1.79e-0412479427684187
Pubmed

Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

SFPQ NONO

2.05e-04849219135240
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

WWTR1 SFPQ NONO SPTY2D1

2.07e-0412949430804502
Pubmed

A human MAP kinase interactome.

WWTR1 SFPQ CDC42BPA

2.14e-044869320936779
Pubmed

14-3-3sigma controls mitotic translation to facilitate cytokinesis.

SFPQ NONO

2.15e-04869217361185
Pubmed

HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis.

SFPQ NONO

2.20e-04879233711283
Pubmed

Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.

SFPQ KIF3C NONO

2.26e-044959328581483
Pubmed

DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.

SFPQ NONO

2.30e-04899222446626
Pubmed

Proteomics analysis of the estrogen receptor alpha receptosome.

SFPQ NONO

2.52e-04939220348541
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

AFF4 NONO CDC42BPA SPTY2D1

2.58e-0413719436244648
InteractionAPBB1 interactions

WWTR1 SFPQ NONO APLP1

1.03e-0619594int:APBB1
InteractionPITX3 interactions

SFPQ NONO

4.96e-06892int:PITX3
InteractionKIF23 interactions

WWTR1 SFPQ AFF4 NONO SPTY2D1

3.68e-05103195int:KIF23
InteractionNEAT1 interactions

SFPQ NONO

4.87e-052492int:NEAT1
InteractionLMO7 interactions

WWTR1 SFPQ NONO

5.38e-0517793int:LMO7
InteractionPPP1R10 interactions

SFPQ NONO SPTY2D1

5.56e-0517993int:PPP1R10
InteractionNKX2-1 interactions

WWTR1 SFPQ NONO

5.66e-0518093int:NKX2-1
InteractionASB18 interactions

SFPQ NONO

6.19e-052792int:ASB18
InteractionSLX4 interactions

SFPQ AFF4 NONO SPTY2D1

7.22e-0557294int:SLX4
InteractionTCERG1 interactions

WWTR1 SFPQ NONO

8.57e-0520793int:TCERG1
InteractionUBE2M interactions

WWTR1 SFPQ KIF3C NONO

1.19e-0465194int:UBE2M
InteractionLINC00624 interactions

SFPQ NONO

1.30e-043992int:LINC00624
InteractionCDK9 interactions

SFPQ AFF4 NONO CDC42BPA

1.45e-0468594int:CDK9
InteractionBFAR interactions

SFPQ NONO

1.98e-044892int:BFAR
InteractionTSPYL5 interactions

SFPQ NONO

2.23e-045192int:TSPYL5
InteractionSMN1 interactions

SFPQ NONO APLP1

2.54e-0429993int:SMN1
InteractionKMT2A interactions

WWTR1 AFF4 NONO

2.94e-0431493int:KMT2A
InteractionIGFBP3 interactions

SFPQ NONO

3.20e-046192int:IGFBP3
InteractionRUNX1 interactions

WWTR1 SFPQ NONO

3.22e-0432493int:RUNX1
InteractionELP4 interactions

WWTR1 AFF4

3.31e-046292int:ELP4
InteractionCDC5L interactions

WWTR1 SFPQ KIF3C NONO

3.42e-0485594int:CDC5L
InteractionMIR138-1 interactions

SFPQ NONO

3.98e-046892int:MIR138-1
InteractionMIR9-3 interactions

SFPQ NONO

4.21e-047092int:MIR9-3
InteractionKAT5 interactions

SFPQ NONO APLP1

4.31e-0435893int:KAT5
InteractionMIR29B2 interactions

SFPQ NONO

4.34e-047192int:MIR29B2
InteractionMIR140 interactions

SFPQ NONO

4.34e-047192int:MIR140
InteractionMIR122 interactions

SFPQ NONO

4.34e-047192int:MIR122
InteractionMIR29B1 interactions

SFPQ NONO

4.58e-047392int:MIR29B1
InteractionMIR18A interactions

SFPQ NONO

4.58e-047392int:MIR18A
InteractionMIR20A interactions

SFPQ NONO

4.71e-047492int:MIR20A
InteractionCSF1R interactions

SFPQ NONO

4.84e-047592int:CSF1R
InteractionMIR15A interactions

SFPQ NONO

4.84e-047592int:MIR15A
InteractionMIR429 interactions

SFPQ NONO

4.97e-047692int:MIR429
InteractionMIR16-1 interactions

SFPQ NONO

4.97e-047692int:MIR16-1
InteractionMIR7-3 interactions

SFPQ NONO

4.97e-047692int:MIR7-3
InteractionMIR199A2 interactions

SFPQ NONO

4.97e-047692int:MIR199A2
InteractionMIR9-2 interactions

SFPQ NONO

5.10e-047792int:MIR9-2
InteractionMIR200A interactions

SFPQ NONO

5.10e-047792int:MIR200A
InteractionSIN3A interactions

WWTR1 SFPQ NONO

5.13e-0438093int:SIN3A
InteractionMIR451A interactions

SFPQ NONO

5.23e-047892int:MIR451A
InteractionMIR98 interactions

SFPQ NONO

5.23e-047892int:MIR98
InteractionMIR92A1 interactions

SFPQ NONO

5.23e-047892int:MIR92A1
InteractionPIN1 interactions

SFPQ NONO APLP1

5.25e-0438393int:PIN1
InteractionSMARCC1 interactions

WWTR1 SFPQ NONO

5.29e-0438493int:SMARCC1
InteractionMIR222 interactions

SFPQ NONO

5.37e-047992int:MIR222
InteractionMIR206 interactions

SFPQ NONO

5.37e-047992int:MIR206
InteractionMIR34C interactions

SFPQ NONO

5.37e-047992int:MIR34C
InteractionMIR1-2 interactions

SFPQ NONO

5.37e-047992int:MIR1-2
InteractionMIR143 interactions

SFPQ NONO

5.50e-048092int:MIR143
InteractionMIR145 interactions

SFPQ NONO

5.64e-048192int:MIR145
InteractionMIR10B interactions

SFPQ NONO

5.78e-048292int:MIR10B
InteractionMIR106A interactions

SFPQ NONO

5.92e-048392int:MIR106A
InteractionAR interactions

SFPQ AFF4 NONO CDC42BPA

6.03e-0499294int:AR
InteractionNR2C1 interactions

SFPQ NONO

6.06e-048492int:NR2C1
InteractionASB3 interactions

SFPQ NONO

6.06e-048492int:ASB3
InteractionMIR200B interactions

SFPQ NONO

6.06e-048492int:MIR200B
InteractionMIR7-2 interactions

SFPQ NONO

6.06e-048492int:MIR7-2
InteractionMIR31 interactions

SFPQ NONO

6.06e-048492int:MIR31
InteractionMIR199A1 interactions

SFPQ NONO

6.06e-048492int:MIR199A1
InteractionMIR16-2 interactions

SFPQ NONO

6.21e-048592int:MIR16-2
InteractionMIR93 interactions

SFPQ NONO

6.21e-048592int:MIR93
InteractionMIR9-1 interactions

SFPQ NONO

6.21e-048592int:MIR9-1
InteractionMIR107 interactions

SFPQ NONO

6.21e-048592int:MIR107
InteractionMIR17 interactions

SFPQ NONO

6.21e-048592int:MIR17
InteractionMIR18B interactions

SFPQ NONO

6.21e-048592int:MIR18B
InteractionMIR20B interactions

SFPQ NONO

6.35e-048692int:MIR20B
InteractionGATA4 interactions

SFPQ NONO SPTY2D1

6.46e-0441193int:GATA4
InteractionMIR29A interactions

SFPQ NONO

6.50e-048792int:MIR29A
InteractionMIR141 interactions

SFPQ NONO

6.65e-048892int:MIR141
InteractionMIR138-2 interactions

SFPQ NONO

6.65e-048892int:MIR138-2
InteractionMIR29C interactions

SFPQ NONO

6.80e-048992int:MIR29C
InteractionMEN1 interactions

SFPQ AFF4 NONO CDC42BPA

6.92e-04102994int:MEN1
InteractionMIR221 interactions

SFPQ NONO

6.96e-049092int:MIR221
InteractionMIR92A2 interactions

SFPQ NONO

6.96e-049092int:MIR92A2
InteractionMIR1-1 interactions

SFPQ NONO

6.96e-049092int:MIR1-1
InteractionNUP35 interactions

WWTR1 SFPQ NONO

7.07e-0442493int:NUP35
InteractionMIR200C interactions

SFPQ NONO

7.11e-049192int:MIR200C
InteractionMIR128-1 interactions

SFPQ NONO

7.27e-049292int:MIR128-1
InteractionMIR155 interactions

SFPQ NONO

7.27e-049292int:MIR155
InteractionMIR214 interactions

SFPQ NONO

7.43e-049392int:MIR214
InteractionMIR205 interactions

SFPQ NONO

7.43e-049392int:MIR205
InteractionMIR19B2 interactions

SFPQ NONO

7.59e-049492int:MIR19B2
InteractionMIRLET7F1 interactions

SFPQ NONO

7.59e-049492int:MIRLET7F1
InteractionTOPORS interactions

SFPQ NONO

7.91e-049692int:TOPORS
InteractionMIRLET7A2 interactions

SFPQ NONO

7.91e-049692int:MIRLET7A2
InteractionMIRLET7C interactions

SFPQ NONO

8.07e-049792int:MIRLET7C
InteractionMIR21 interactions

SFPQ NONO

8.07e-049792int:MIR21
InteractionMIRLET7F2 interactions

SFPQ NONO

8.07e-049792int:MIRLET7F2
InteractionMIR363 interactions

SFPQ NONO

8.07e-049792int:MIR363
InteractionPRPF40A interactions

WWTR1 SFPQ NONO

8.19e-0444693int:PRPF40A
InteractionMIR106B interactions

SFPQ NONO

8.24e-049892int:MIR106B
InteractionFAM76B interactions

SFPQ NONO

8.41e-049992int:FAM76B
InteractionMIR128-2 interactions

SFPQ NONO

8.41e-049992int:MIR128-2
InteractionNDN interactions

WWTR1 SFPQ NONO

8.57e-0445393int:NDN
InteractionPER1 interactions

SFPQ NONO

8.58e-0410092int:PER1
InteractionMIR19A interactions

SFPQ NONO

8.58e-0410092int:MIR19A
InteractionARRB2 interactions

SFPQ AFF4 NONO

8.62e-0445493int:ARRB2
InteractionMIRLET7B interactions

SFPQ NONO

8.75e-0410192int:MIRLET7B
InteractionMIRLET7D interactions

SFPQ NONO

8.75e-0410192int:MIRLET7D
InteractionMIR25 interactions

SFPQ NONO

8.75e-0410192int:MIR25
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

SFPQ NONO

5.90e-0418142694
GeneFamilyRNA binding motif containing

SFPQ NONO

8.16e-0421342725
CoexpressionCHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN

WWTR1 SFPQ KIF3C NONO

1.15e-0546594M9192
CoexpressionGSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP

KIF3C NONO APLP1

3.50e-0519993M7379
CoexpressionCHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN

KIF3C APLP1

1.38e-045292M12895
CoexpressionNAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE

SFPQ AFF4 SPTY2D1

2.08e-0436393M41103
CoexpressionYOSHIMURA_MAPK8_TARGETS_DN

SFPQ KIF3C SPTY2D1

2.36e-0437993M1885
CoexpressionNAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN

SFPQ AFF4 SPTY2D1

3.47e-0443293M41149
CoexpressionROPERO_HDAC2_TARGETS

CDC42BPA APLP1

6.39e-0411292M8759
CoexpressionKIM_ALL_DISORDERS_CALB1_CORR_UP

KIF3C NONO APLP1

6.91e-0454793M2110
CoexpressionFLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN

WWTR1 NONO CDC42BPA

7.14e-0455393M1475
CoexpressionCERVERA_SDHB_TARGETS_1_UP

KIF3C APLP1

7.33e-0412092M15549
CoexpressionFLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP

WWTR1 NONO CDC42BPA

7.71e-0456893M4023
CoexpressionLAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR

WWTR1 CDC42BPA

1.17e-0315292M39243
CoexpressionCASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN

SFPQ NONO CDC42BPA

1.24e-0366993M18635
CoexpressionKIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP

KIF3C NONO APLP1

1.30e-0368093M2107
CoexpressionGSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN

NONO SPTY2D1

1.44e-0316992M8937
CoexpressionXIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_669C_3P_GENES

KIF3C CDC42BPA

1.69e-0318392MM17506
CoexpressionJISON_SICKLE_CELL_DISEASE_DN

SFPQ NONO

1.75e-0318692M4911
CoexpressionGSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP

SFPQ SPTY2D1

1.90e-0319492M4234
CoexpressionGSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP

NONO APLP1

1.92e-0319592M5318
CoexpressionGSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP

SFPQ KIF3C

1.97e-0319892M3131
CoexpressionGSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN

WWTR1 SPATA19

1.97e-0319892M7916
CoexpressionGSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN

SFPQ AFF4

1.97e-0319892M7708
CoexpressionGSE45365_NK_CELL_VS_BCELL_UP

WWTR1 SPTY2D1

1.97e-0319892M10031
CoexpressionHALLMARK_MITOTIC_SPINDLE

KIF3C CDC42BPA

1.99e-0319992M5893
CoexpressionGSE22886_NEUTROPHIL_VS_MONOCYTE_DN

SFPQ NONO

1.99e-0319992M4467
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP

SFPQ AFF4

1.99e-0319992M7712
CoexpressionGSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP

AFF4 KIF3C

1.99e-0319992M3627
CoexpressionGSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN

SFPQ KIF3C

1.99e-0319992M3853
CoexpressionGSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN

KIF3C NONO

1.99e-0319992M7351
CoexpressionONKEN_UVEAL_MELANOMA_UP

WWTR1 SFPQ CDC42BPA

2.00e-0379093M12490
CoexpressionGSE17721_LPS_VS_CPG_2H_BMDC_DN

CDC42BPA APLP1

2.01e-0320092M3991
CoexpressionGSE14769_20MIN_VS_360MIN_LPS_BMDM_DN

KIF3C CDC42BPA

2.01e-0320092M3513
CoexpressionGSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN

WWTR1 SFPQ

2.01e-0320092M5286
CoexpressionGSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP

AFF4 APLP1

2.01e-0320092M8596
CoexpressionGSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN

NONO APLP1

2.01e-0320092M5099
CoexpressionGSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN

SFPQ CDC42BPA

2.01e-0320092M5582
CoexpressionGSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP

KIF3C APLP1

2.01e-0320092M5122
CoexpressionGSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP

KIF3C NONO

2.01e-0320092M6611
CoexpressionGSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP

SFPQ NONO

2.01e-0320092M5781
CoexpressionGSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN

WWTR1 APLP1

2.01e-0320092M9368
CoexpressionGSE557_WT_VS_I_AB_KO_DC_DN

SFPQ AFF4

2.01e-0320092M6010
CoexpressionGSE3982_MAC_VS_BCELL_UP

WWTR1 AFF4

2.01e-0320092M5494
CoexpressionGSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN

SFPQ KIF3C

2.01e-0320092M6956
CoexpressionBUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP

SFPQ AFF4 KIF3C

2.24e-0382293M6782
CoexpressionBIDUS_METASTASIS_UP

SFPQ NONO

2.45e-0322192M15866
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_200

SFPQ NONO

2.16e-051792gudmap_developingGonad_e16.5_epididymis_200_k3
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_200

SFPQ NONO

4.77e-052592gudmap_developingGonad_e14.5_ epididymis_200_k3
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500

SFPQ NONO

1.24e-044092gudmap_developingGonad_e16.5_epididymis_500_k5
CoexpressionAtlasDevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000

SFPQ NONO SPTY2D1

1.46e-0426193gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500

SFPQ NONO

1.94e-045092gudmap_developingGonad_e14.5_ epididymis_500_k1
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000

SFPQ NONO

7.58e-049992gudmap_developingGonad_e14.5_ epididymis_1000_k1
ToppCellBronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

WWTR1 CDC42BPA APLP1

7.02e-06199936a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32

SFPQ NONO

2.68e-04124921483be8700eca7e2c288784a290d945d4022b17f
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32

SFPQ NONO

3.22e-04136923e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32

SFPQ NONO

3.22e-04136920185486c39700dd2f72d79be6d283494dd8379c9
ToppCelldroplet-Liver-Hepatocytes-24m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF3C APLP1

4.29e-041579216581e2399a211633f870dce326c75ff4b6a5fe6
ToppCelldroplet-Liver-Hepatocytes-24m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF3C APLP1

4.29e-0415792cbb08d5c151f0622123276926a2a15bb7d271e90
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDC42BPA APLP1

4.62e-04163921feb4ef7b8abcfca9a72c8d13c40548de79e7db2
ToppCell3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WWTR1 KIF3C

5.20e-041739285083b9ce20351dd69aa2327ad087b848b4307ff
ToppCellASK452-Endothelial-Lymphatic|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

KIF3C CDC42BPA

5.38e-0417692b4d280ecc07701d526f50d44c45ea91b3eeb00b1
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32

SFPQ NONO

5.63e-041809244988c34861df359a68376500c42a64fbcc4b431
ToppCell10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

WWTR1 SPATA19

5.75e-0418292ed487f3a774812caa2903a646b60c86edcc1e65e
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32

SFPQ NONO

5.81e-0418392f20b0d71f857ac35868fd80531050ad8b6091716
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF4 SPTY2D1

5.94e-0418592eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCellHippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32

SFPQ NONO

6.13e-04188928bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SFPQ AFF4

6.26e-0419092d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WWTR1 CDC42BPA

6.26e-0419092474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCellStriatum-Macroglia-POLYDENDROCYTE|Striatum / BrainAtlas - Mouse McCarroll V32

SFPQ NONO

6.33e-04191926bc9c7c86040f3ebce08c350e625e345581d4550
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WWTR1 CDC42BPA

6.33e-041919250601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WWTR1 KIF3C

6.46e-0419392bd0027fa97de41ae22ff64a61c8e217496f122ca
ToppCellCOPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class

WWTR1 CDC42BPA

6.46e-04193921c701b6ab5f0f0239634adac94fa1c92bf3c36f4
ToppCellCV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster

AFF4 SPTY2D1

6.59e-04195922b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCellproximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

WWTR1 KIF3C

6.59e-0419592ae9d61011e95f7840cbb154738c79745fd29943e
ToppCellproximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

WWTR1 KIF3C

6.59e-0419592c48ff83c48342875f06c6c9e7d5bc6084a992848
ToppCellproximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

WWTR1 KIF3C

6.59e-04195928592d0332bc82a91e173680cfd1afc5ee189b289
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WWTR1 CDC42BPA

6.59e-0419592023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WWTR1 CDC42BPA

6.59e-0419592b0979c1b5e4576468b8fe4e9027650859e598b34
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF4 APLP1

6.59e-04195923e519cffa6144a62b06124642a14c9ff39b76554
ToppCellCV-Moderate-6|CV / Virus stimulation, Condition and Cluster

AFF4 SPTY2D1

6.66e-04196927bced0cc2112697593c478fa291b8ed3941fb811
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SFPQ AFF4

6.66e-0419692151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCellnucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WWTR1 CDC42BPA

6.66e-0419692686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCellnucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WWTR1 CDC42BPA

6.73e-0419792ebf9be068eaa658493fa7884fd19f34642922acb
ToppCellfacs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

AFF4 CDC42BPA

6.73e-0419792e77016d64b1cac9825fec7cfe5071f1567401187
ToppCellfacs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CDC42BPA APLP1

6.73e-0419792a1f7eec1aca03432caa8fe817ff6d24b29d4062d
ToppCellfacs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF4 CDC42BPA

6.73e-04197920353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCellfacs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

WWTR1 CDC42BPA

6.73e-04197923fe665c0277d091290b63f0dd24c0c6536a45309
ToppCell5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WWTR1 KIF3C

6.73e-0419792407231542fa1ffd540dcb61435c0575e71f59725
ToppCellfacs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF4 NONO

6.80e-04198922f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WWTR1 KIF3C

6.80e-04198925d42f4fda2081ea3e9f62a00e7eea702e0d0be7d
ToppCell5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WWTR1 KIF3C

6.80e-041989299d6a64f3410dae3019161feef20a8f06081a24b
ToppCellfacs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF4 NONO

6.80e-0419892f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCellBrain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type.

KIF3C APLP1

6.80e-041989260d8d3bbd754ffde41c50013d822667b185a9751
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

WWTR1 SFPQ

6.80e-041989277517df37dc894c78ef1e2b24dd7ba31f928bdb7
ToppCellNS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

WWTR1 CDC42BPA

6.80e-0419892a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

KIF3C APLP1

6.87e-041999277b4aa00f14b86ef5db0490be98787e063979541
ToppCell3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WWTR1 APLP1

6.87e-04199920075bcc7d2a5031e76a24cb176e16ac998d846fd
ToppCellfacs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WWTR1 CDC42BPA

6.87e-041999267f78c070c56e44fba36542041bf7fa1c291807c
ToppCellfacs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF4 NONO

6.87e-04199928d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCellfacs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WWTR1 CDC42BPA

6.87e-04199921ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type.

KIF3C APLP1

6.87e-0419992a255484ba77bd2741a541da278efc8cf4abbe570
ToppCellFibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

WWTR1 CDC42BPA

6.87e-041999240de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCellTracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

KIF3C APLP1

6.87e-04199922b567b6fd8addf059bbf2b72c55a7647aefdc595
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

KIF3C APLP1

6.93e-042009271cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type.

WWTR1 SPTY2D1

6.93e-04200922cc98abf11f5b58707de45a2282f03d47f00f035
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SFPQ AFF4

6.93e-042009212f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type.

WWTR1 SPTY2D1

6.93e-04200920f7431f670f3a175377cefae3479403a881bb8fb
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type.

KIF3C APLP1

6.93e-0420092af99d90070e2933fd2e9512590c6cf3bd6e15539
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Neuronal|6m / Sample Type, Dataset, Time_group, and Cell type.

KIF3C APLP1

6.93e-0420092cedbc47b1defb5973cf7ab6baaa2d6f2fd481f88
ToppCellCOVID-19|World / Disease, condition lineage and cell class

SFPQ AFF4

6.93e-04200927dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellBronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

WWTR1 APLP1

6.93e-04200927547d6339f9380d031cfd2cce21ac9a12491e085
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Cortical_neuron|6m / Sample Type, Dataset, Time_group, and Cell type.

KIF3C APLP1

6.93e-04200926f7ff0533339fcc9d316f2c77334a79c1409ec4f
DrugPlant Oils

WWTR1 SFPQ AFF4 SPTY2D1

2.57e-0549694ctd:D010938
DrugLuteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A

WWTR1 KIF3C CDC42BPA

4.63e-05190933379_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

AFF4 KIF3C CDC42BPA

4.70e-05191935204_DN
DrugTetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A

WWTR1 AFF4 APLP1

4.85e-05193936209_UP
DrugGW8510; Up 200; 10uM; MCF7; HT_HG-U133A

SFPQ CDC42BPA APLP1

4.85e-05193937080_UP
DrugFlufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A

WWTR1 CDC42BPA APLP1

5.00e-05195932104_DN
DrugHecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A

WWTR1 SFPQ AFF4

5.00e-05195933457_DN
DrugNizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A

WWTR1 AFF4 KIF3C

5.00e-05195933047_DN
DrugSulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A

WWTR1 SFPQ CDC42BPA

5.08e-05196931495_UP
Drugtopiramate; Down 200; 3uM; MCF7; HT_HG-U133A_EA

WWTR1 CDC42BPA APLP1

5.08e-0519693915_DN
DrugAmodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A

AFF4 KIF3C CDC42BPA

5.16e-05197933186_DN
DrugAlprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A

AFF4 CDC42BPA APLP1

5.16e-05197937358_DN
DrugBupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

WWTR1 AFF4 CDC42BPA

5.16e-05197933180_DN
DrugChicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA APLP1

5.31e-05199933266_DN
DrugIoxaglic acid [59017-64-0]; Up 200; 3.2uM; HL60; HT_HG-U133A

WWTR1 KIF3C CDC42BPA

5.31e-05199932966_UP
DrugTerbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A

WWTR1 AFF4 APLP1

5.31e-05199936240_UP
DrugRilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; HL60; HT_HG-U133A

AFF4 KIF3C CDC42BPA

5.31e-05199933133_UP
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

SFPQ KIF3C CDC42BPA

5.31e-05199936963_DN
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA APLP1

5.31e-05199931470_UP
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; HL60; HT_HG-U133A

WWTR1 KIF3C CDC42BPA

5.39e-05200931281_UP
Drugbromovanin

SFPQ NONO

1.08e-0312792ctd:C515564
DrugProscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A

SFPQ AFF4

1.71e-03160924404_UP
DrugDigoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A

SFPQ AFF4

1.71e-03160925275_UP
DrugLanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A

SFPQ AFF4

1.75e-03162923771_UP
DrugProscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A

SFPQ AFF4

1.75e-03162927340_UP
DrugLanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A

SFPQ AFF4

1.80e-03164923852_UP
DrugLanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A

SFPQ AFF4

1.80e-03164923963_UP
DrugHelveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A

SFPQ AFF4

1.82e-03165923770_UP
DrugDigoxin [20830-75-5]; Up 200; 5.2uM; PC3; HT_HG-U133A

SFPQ AFF4

1.91e-03169926724_UP
DrugDigoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A

SFPQ AFF4

1.93e-03170924680_UP
DrugStrophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A

SFPQ AFF4

1.95e-03171925026_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

WWTR1 KIF3C

2.02e-03174921166_UP
DrugWithaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A

WWTR1 SFPQ

2.13e-03179924554_DN
Druggeldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A

KIF3C APLP1

2.23e-03183926946_UP
DrugCPG-oligonucleotide

SFPQ NONO

2.25e-0318492ctd:C408982
DrugHydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; HL60; HG-U133A

KIF3C NONO

2.25e-03184921772_DN
DrugNiclosamide [50-65-7]; Down 200; 12.2uM; PC3; HG-U133A

WWTR1 SFPQ

2.30e-03186921916_DN
DrugHarmine hydrochloride [343-27-1]; Down 200; 16uM; HL60; HG-U133A

SFPQ CDC42BPA

2.33e-03187921758_DN
DrugNifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA

2.35e-03188924835_DN
DrugRescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA

2.35e-03188924386_UP
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A

AFF4 KIF3C

2.37e-03189926960_UP
Drugcarbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

CDC42BPA APLP1

2.37e-0318992835_UP
DrugFluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A

WWTR1 CDC42BPA

2.40e-03190924114_DN
DrugGabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A

CDC42BPA APLP1

2.40e-03190923253_DN
DrugDoxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A

WWTR1 AFF4

2.42e-03191927195_UP
Drug17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA

2.42e-03191926933_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A

AFF4 CDC42BPA

2.45e-03192923114_UP
Druggeldanamycin; Down 200; 1uM; MCF7; HG-U133A

WWTR1 KIF3C

2.45e-0319292611_DN
DrugNorethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A

KIF3C APLP1

2.45e-03192921696_UP
Drug2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A

KIF3C APLP1

2.45e-03192925206_UP
Drug3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA

2.45e-03192923382_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

WWTR1 KIF3C

2.45e-03192926978_DN
DrugTiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A

WWTR1 APLP1

2.45e-03192926013_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

WWTR1 KIF3C

2.45e-03192921646_DN
DrugC75; Down 200; 10uM; MCF7; HT_HG-U133A

CDC42BPA APLP1

2.45e-03192926423_DN
DrugBretylium tosylate [61-75-6]; Down 200; 9.6uM; HL60; HT_HG-U133A

WWTR1 KIF3C

2.47e-03193923057_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A

KIF3C CDC42BPA

2.47e-03193923077_DN
DrugCP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A

CDC42BPA APLP1

2.47e-03193924380_DN
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A

CDC42BPA APLP1

2.47e-03193926938_UP
DrugCP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A

SFPQ CDC42BPA

2.47e-03193923908_DN
DrugDanazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

WWTR1 KIF3C

2.47e-03193925315_UP
DrugMethylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A

AFF4 CDC42BPA

2.47e-03193923378_DN
DrugGallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A

WWTR1 CDC42BPA

2.47e-03193926215_DN
DrugAzacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A

SFPQ CDC42BPA

2.47e-03193923348_UP
DrugTiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA

2.47e-03193922852_UP
Drugchlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A

SFPQ CDC42BPA

2.50e-03194921642_DN
DrugLasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A

KIF3C CDC42BPA

2.50e-03194923021_DN
DrugPimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A

WWTR1 CDC42BPA

2.50e-03194927468_DN
DrugSulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; HL60; HT_HG-U133A

KIF3C CDC42BPA

2.50e-03194922742_DN
DrugBenzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A

WWTR1 AFF4

2.50e-03194923169_DN
DrugMethyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A

SFPQ APLP1

2.50e-03194924325_DN
DrugMefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A

WWTR1 CDC42BPA

2.50e-03194921699_DN
DrugRetrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A

AFF4 KIF3C

2.50e-03194922784_DN
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA

2.50e-03194925216_DN
DrugThonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A

CDC42BPA APLP1

2.50e-03194926457_UP
DrugMemantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A

AFF4 CDC42BPA

2.50e-03194927354_DN
DrugFusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A

CDC42BPA APLP1

2.50e-03194923245_UP
DrugErythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A

WWTR1 APLP1

2.53e-03195925329_UP
Drug5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA

WWTR1 CDC42BPA

2.53e-0319592834_UP
DrugAcetohexamide [968-81-0]; Up 200; 12.4uM; HL60; HT_HG-U133A

AFF4 CDC42BPA

2.53e-03195921870_UP
DrugGallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A

WWTR1 AFF4

2.53e-03195926215_UP
DrugPindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A

KIF3C CDC42BPA

2.53e-03195926834_DN
DrugCP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A

AFF4 APLP1

2.53e-03195923909_DN
DrugPentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A

WWTR1 APLP1

2.53e-03195924396_DN
DrugButoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A

WWTR1 APLP1

2.53e-03195925388_DN
DrugDL-PPMP; Down 200; 2uM; MCF7; HT_HG-U133A_EA

SFPQ CDC42BPA

2.53e-03195921121_DN
DiseaseMiT family translocation renal cell carcinoma

SFPQ NONO

1.74e-06792C4518356
Diseasebiological sex

SPATA19 CDC42BPA

2.10e-0323092PATO_0000047
Diseaseamino acid measurement

WWTR1 KIF3C

1.71e-0267892EFO_0005134

Protein segments in the cluster

PeptideGeneStartEntry
DLEERRMRQINEVMR

APLP1

316

P51693
MNREDRNVLRMKERE

AFF4

1

Q9UHB7
REEEMRRQQEEMMRR

NONO

351

Q15233
RRQQEEMMRRQQEGF

NONO

356

Q15233
RREREMQQEMMLRDE

KIF3C

551

O14782
EMRREEEEMQRRRAK

SPTY2D1

666

Q68D10
FRVPEEERMQQRREM

CDC42BPA

1546

Q5VT25
EERMQQRREMLRDPE

CDC42BPA

1551

Q5VT25
RQDLMRRQEELRRME

SFPQ

536

P23246
RQEEERRRREEEMMI

SFPQ

566

P23246
RRRREEEMMIRQREM

SFPQ

571

P23246
RQREMEEQMRRQREE

SFPQ

581

P23246
MTEDIMRDRIEQVRR

SPATA19

131

Q7Z5L4
QMERERIRMRQEELM

WWTR1

241

Q9GZV5